Filter
1046
Filtered Results: 1046
Text search:
DNA
Featured
Recommendations
116
New Publications
271
Language
Document type
No document type
589
Guidelines
156
Studies & Reports
148
Manuals
58
Fact sheets
38
Strategic & Response Plan
27
Training Material
16
Resource Platforms
5
Situation Updates
4
Infographics
3
Brochures
1
Videos
1
Countries / Regions
India
80
Global
29
Kenya
24
Tanzania
22
Mozambique
22
Ethiopia
21
Zambia
19
Western and Central Europe
19
Nepal
17
South Africa
17
Malawi
17
Brazil
17
Germany
16
Bangladesh
15
Latin America and the Carribbean
15
Indonesia
14
Africa
14
Nigeria
12
Congo, Democratic Republic of
12
Ghana
11
Philippines
11
Rwanda
10
Uganda
9
Zimbabwe
9
Namibia
9
Argentina
8
Lesotho
8
Asia
8
Paraguay
7
Burkina Faso
6
Liberia
6
Syria
6
Middle East and North Africa
6
Angola
5
Myanmar / Burma
5
West and Central Africa
5
Senegal
4
USA
4
Eswatini/ Swaziland
4
Botswana
4
Eastern Europe
4
Sierra Leone
3
Cameroon
3
Haiti
3
Cambodia
3
Thailand
3
China
3
Benin
3
Ukraine
3
East and Southern Africa
3
Eastern Europe and Central Asia
3
Venezuela
3
Guinea-Bissau
2
Pakistan
2
Iraq
2
Lebanon
2
Chad
2
Peru
2
Ecuador
2
Bolivia
2
Madagascar
2
Vietnam
2
United Kingdom
2
Guinea
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Togo
1
Somalia
1
South Sudan
1
Afghanistan
1
Turkey
1
Colombia
1
Sri Lanka
1
Yemen
1
South–East Asia Region
1
Mongolia
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
North America
1
Jamaica
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
427
Clinical Guidelines
145
Pharmacy & Technologies
39
Public Health
37
Women & Child Health
32
Key Resources
25
Capacity Building
12
Toolboxes
TB
97
HIV
94
COVID-19
72
NTDs
69
Rapid Response
40
Mental Health
37
AMR
34
Refugee
29
Planetary Health
26
Pharmacy
23
Caregiver
18
NCDs
16
Ebola
14
Natural Hazards
14
Specific Hazards
11
Global Health Education
11
Conflict
8
Social Ethics
8
Cholera
7
Zika
7
Disability
4
Polio
3
Health Financing Toolbox
1
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to ...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
Guía de medicamentos esenciales para primer nivel de atención – Edición 2019
Desde el 2010, los Estados miembros de la Organización Panamericana
de la Salud (OPS) han asumido el compromiso de impulsar la eliminación de la transmisión materno infantil (ETMI) de la infección por el VIH y la sífilis. Estos compromisos se renovaron y ampliaron en el año 2016 mediante la...
Los objetivos de las guías son brindar directrices para optimizar el cuidado de la mayoría de los pacientes afectados por los VHB y VHC. Sin embargo, no reemplazan el criterio médico en la valoración y abordaje del paciente individual. En situaciones especiales, el mejor enfoque en el diagnóst...
Resumen para Equipos de Salud Edición 2021-2022
Las presentes recomendaciones se encuentran dirigidas a los miembros del equipo de salud que asisten niñas, niños y adolescentes (NNyA) que viven con VIH. También se dirigen a los responsables jurisdiccionales que participan en el proceso de gesti...
Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and...
Esta carpeta ofrece información básica acerca de la estrategia de tamizaje basada en el test de VPH. Tiene como principales destinatariosa los integrantes del equipo de salud que realizan las tomas de las muestras para el tamizaje en las provincias que incorporaron esta nueva tecnología [ginecól...
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive...
